Borsche M, Pereira SL, Klein C, Grnewald A
Phase Weeks 1-2 Draw volume 7.5 units (0.075 mL) Total blend delivered ~2.0 mg total blend GHK-Cu ~1.25 mg KPV ~250 mcg BPC-157 ~250 mcg TB-500 ~250 mcg Phase Weeks 3-4 Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Phase Weeks 5-8 Draw volume 22.5 units (0.225 mL) Total blend delivered ~6.0 mg total blend GHK-Cu ~3.75 mg KPV ~750 mcg BPC-157 ~750 mcg TB-500 ~750 mcg Phase Weeks 9-12 (taper) Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Blend ratio 50 / 10 / 10 / 10 mg GHK-Cu dominant Select a draw volume from the titration table above to see the approximate amount of each peptide delivered
The green curve shows the NAC rescue of the male by the protocol described in the text starting The black curve in Figure 5 shows the response of the male to an 18-gm dose of APAP if not treated
Some older researchers report dramatic results at doses that produce subtle effects in younger users
Its ability to modulate thousands of genes, stimulate tissue regeneration, suppress chronic inflammation, and support skin, hair, and neural health through a naturally occurring mechanism makes it a unique tool in the peptide researchers toolkit
[DOI] [PubMed] [Google Scholar] World Health Organization (2017) Depression and Other Common Mental Disorders: Global Health Estimates, World Health Organization, Geneva
